In Sweden, the research & development by business enterprise, pharmaceutical industry in current ppp $ stands at 1,184.53 million, reflecting an increase of 200.50 million (20.4%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Sweden
No matching regions
Similar regions to Sweden
Business R&D pharmaceutical in current PPP $
More indicators for Sweden
Government R&D in security as % of government support
2.1%
-0.33%
(2021)
Higher-education-finacing R&D financed by general university in local currency
181,501.95M
+16,181.95M
(2021)
R&D financed by rest of the world in local currency
218,622.84M
+67,392.84M
(2021)
Government R&D financed by rest of the world in local currency
1,858.26M
-1,101.74M
(2021)
Business R&D financed by rest of the world in local currency
185,804.74M
+67,514.74M
(2021)
Non-profit R&D growth rate
-0.36%
-1.64%
(2022)
Sweden Business R&D pharmaceutical in current PPP $ between 2007 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 1,184.53M | +200.50M |
| 2020 | 984.03M | +170.57M |
| 2019 | 813.46M | +15.76M |
| 2018 | 797.70M | -53.78M |
| 2017 | 851.48M | +23.51M |
| 2016 | 827.97M | -28.52M |
| 2015 | 856.50M | +94.09M |
| 2014 | 762.40M | -47.24M |
| 2013 | 809.64M | -19.76M |
| 2012 | 829.40M | -47.13M |
| 2011 | 876.52M | +130.04M |
| 2010 | 746.48M | +38.15M |
| 2009 | 708.33M | -224.69M |
| 2008 | 933.02M | -27.09M |
| 2007 | 960.11M |